Andrew W. Robertson, n/a

Senior Director
Generate Biomedicines
San Francisco, California, United States

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 89 - First-in-human study of a novel half-life extended monoclonal antibody (GB-0669) against SARS-CoV2 and related sarbecoviruses

  Thursday, October 17, 2024
  10:54 AM – 11:06 AM US PT